PIK3CA-CDKN2A clonal evolution in metastatic breast cancer and multiple points cell-free DNA analysis

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1475-2867

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: PIK3CA-CDKN2A clonal evolution in metastatic breast cancer and multiple points cell-free DNA analysis ; volume:19 ; number:1 ; day:28 ; month:10 ; year:2019 ; pages:1-4 ; date:12.2019
Cancer cell international ; 19, Heft 1 (28.10.2019), 1-4, 12.2019

Creator: Palmieri, Maria
Baldassarri, Margherita
Fava, Francesca
Fabbiani, Alessandra
Campennì, Giuseppe Maria
Mencarelli, Maria Antonietta
Tita, Rossella
Marsili, Stefania
Renieri, Alessandra
Frullanti, Elisa

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12935-019-0991-y

URN: urn:nbn:de:101:1-2020022621134913756022

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:50 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Palmieri, Maria
Baldassarri, Margherita
Fava, Francesca
Fabbiani, Alessandra
Campennì, Giuseppe Maria
Mencarelli, Maria Antonietta
Tita, Rossella
Marsili, Stefania
Renieri, Alessandra
Frullanti, Elisa
SpringerLink (Online service)

Other Objects (12)

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis

Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer

Carcinogenesis of PIK3CA

PIK3CA-mutations in breast cancer

Hochschulschrift

PIK3CA-Amplifikationen in humanen Lungenkarzinomen

$Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients$

Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients

Discordance of PIK3CA mutational status between primary and metastatic breast cancer: a systematic review and meta-analysis

High resolution melting analysis of KRAS, BRAF and PIK3CA in KRASexon 2 wild-type metastatic colorectal cancer

Prävalenz von PIK3CA-Genmutationen beim Mammakarzinom

The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors

A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions

Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis

Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer

Carcinogenesis of PIK3CA

PIK3CA-mutations in breast cancer

Hochschulschrift

PIK3CA-Amplifikationen in humanen Lungenkarzinomen

$Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients$

Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients

Discordance of PIK3CA mutational status between primary and metastatic breast cancer: a systematic review and meta-analysis

High resolution melting analysis of KRAS, BRAF and PIK3CA in KRASexon 2 wild-type metastatic colorectal cancer

Prävalenz von PIK3CA-Genmutationen beim Mammakarzinom

The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors

A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions

Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis

Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer

Carcinogenesis of PIK3CA

PIK3CA-mutations in breast cancer

Hochschulschrift

PIK3CA-Amplifikationen in humanen Lungenkarzinomen

$Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients$

Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients

Discordance of PIK3CA mutational status between primary and metastatic breast cancer: a systematic review and meta-analysis

High resolution melting analysis of KRAS, BRAF and PIK3CA in KRASexon 2 wild-type metastatic colorectal cancer

Prävalenz von PIK3CA-Genmutationen beim Mammakarzinom

The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors

A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions

Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

PIK3CA-CDKN2A clonal evolution in metastatic breast cancer and multiple points cell-free DNA analysis

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis

Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer

Carcinogenesis of PIK3CA

PIK3CA-mutations in breast cancer

PIK3CA-Amplifikationen in humanen Lungenkarzinomen

Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients

Discordance of PIK3CA mutational status between primary and metastatic breast cancer: a systematic review and meta-analysis

High resolution melting analysis of KRAS, BRAF and PIK3CA in KRASexon 2 wild-type metastatic colorectal cancer

Prävalenz von PIK3CA-Genmutationen beim Mammakarzinom

The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors

A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions

Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis

Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer

Carcinogenesis of PIK3CA

PIK3CA-mutations in breast cancer

PIK3CA-Amplifikationen in humanen Lungenkarzinomen

Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients

Discordance of PIK3CA mutational status between primary and metastatic breast cancer: a systematic review and meta-analysis

High resolution melting analysis of KRAS, BRAF and PIK3CA in KRASexon 2 wild-type metastatic colorectal cancer

Prävalenz von PIK3CA-Genmutationen beim Mammakarzinom

The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors

A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions

Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis

Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer

Carcinogenesis of PIK3CA

PIK3CA-mutations in breast cancer

PIK3CA-Amplifikationen in humanen Lungenkarzinomen

Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients

Discordance of PIK3CA mutational status between primary and metastatic breast cancer: a systematic review and meta-analysis

High resolution melting analysis of KRAS, BRAF and PIK3CA in KRASexon 2 wild-type metastatic colorectal cancer

Prävalenz von PIK3CA-Genmutationen beim Mammakarzinom

The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors

A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions

Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer

Related objects

Reset password